Bausch & LombBLCO +2.58%77 PB Ratio is 0.89 as of Jun. 26, 2026, which is 5% above its 10-year median of 0.85. GuruFocus rates BLCO with a GF Score™ of 77/100 and a GF Value™ of $18.29 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Bausch & Lomb ranks better than 80.71% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Bausch & Lomb's share price is $15.91. Bausch & Lomb's Book Value per Share for the quarter that ended in Mar. 2026 was $17.90. Hence, Bausch & Lomb's PB Ratio of today is 0.89.
Warning Sign:
Bausch & Lomb Corp stock PB Ratio (=0.92) is close to 1-year high of 0.99.
The historical rank and industry rank for Bausch & Lomb's PB Ratio or its related term are showing as below:
BLCO'
s PB Ratio Range Over the Past 10 Years
Min: 0.6 Med: 0.85 Max: 1.13
Current: 0.92
During the past 8 years, Bausch & Lomb's highest PB Ratio was 1.13. The lowest was 0.60. And the median was 0.85.
BLCO's PB Ratio is ranked better than 80.71% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs BLCO: 0.92
During the past 12 months, Bausch & Lomb's average Book Value Per Share Growth Rate was -5.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.40% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Bausch & Lomb was -2.70% per year. The lowest was -10.30% per year. And the median was -9.25% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Bausch & Lomb PB Ratio Related Terms
Bausch & Lomb PB Ratio Historical Data
* Premium members only.
The historical data trend for Bausch & Lomb's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Bausch & Lomb's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch & Lomb PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bausch & Lomb's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Bausch & Lomb's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bausch & Lomb (BLCO) has a PB Ratio of 0.89 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bausch & Lomb and its competitors. This is near median its historical median of 0.85. Over the past decade, Bausch & Lomb's PB Ratio has ranged from 0.60 to 1.13. According to the industry distribution chart, Bausch & Lomb ranks #152 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 19.3%.
Is Bausch & Lomb's PB Ratio too high?
Bausch & Lomb's current PB Ratio of 0.89 is near median its 10-year median of 0.85. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 1.13. The Medical Devices & Instruments industry median PB Ratio is 2.02. Bausch & Lomb's value of 0.89 is 55.9% below this industry median. Based on the distribution chart, Bausch & Lomb ranks #152 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bausch & Lomb has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bausch & Lomb's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bausch & Lomb ranks #152 out of 788 companies for PB Ratio. This places Bausch & Lomb in the top 19% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.02. Bausch & Lomb's value of 0.89 is 55.9% below this benchmark. Historically, Bausch & Lomb's own PB Ratio has ranged from 0.60 to 1.13 over the past decade. While the company's 10-year median is 0.85 vs. the industry median of 2.02, Bausch & Lomb has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bausch & Lomb's current PB Ratio of 0.89 is 55.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bausch & Lomb and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bausch & Lomb's current PB Ratio is 0.89, which is near median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch & Lomb stock overvalued right now?
Based on GuruFocus' analysis, Bausch & Lomb (BLCO) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.29, compared to a current price of $15.91 — trading 13% below its estimated fair value. The current PB Ratio is 0.89, which is near median its 10-year median of 0.85 and 55.9% below the Medical Devices & Instruments industry median of 2.02. Bausch & Lomb's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Bausch & Lomb (BLCO), the current PB Ratio is 0.89 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bausch & Lomb (BLCO) Overvalued in 2026?
Based on GuruFocus' analysis, Bausch & Lomb stock appears to be undervalued.
The current stock price of $15.91 is trading 13% below its estimated GF Value™ of $18.29.
GuruFocus considers Bausch & Lomb to be Modestly Undervalued.
Key valuation signals for BLCO:
PB Ratio: 0.89 (near median its 10-year median of 0.85)
GF Value™: $18.29 vs. price of $15.91 (13% below fair value)
Industry Position: 55.9% below the Medical Devices & Instruments median (#152 of 788)
No single metric tells the full story. See the BLCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
77GF Score
Get the complete analysis for BLCO
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLCO has been successfully added to your 
